0.6420
-0.0172
(-2.61%)
At close: April 9 at 4:00:00 PM EDT
0.6408
-0.00
(-0.19%)
After hours: April 9 at 7:40:07 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Total Revenue
5,442.0760
5,625.1240
905.0490
--
Cost of Revenue
5,175.1300
5,152.5430
1,048.3540
--
Gross Profit
266.9460
472.5810
-143.3050
--
Operating Expense
9,143.3370
9,515.4320
49,215.5610
3,652.4330
Operating Income
-8,876.3910
-9,042.8510
-49,358.8660
-3,652.4330
Net Non Operating Interest Income Expense
-132.1790
287.1650
536.3170
-2.1300
Other Income Expense
512.1310
396.4410
-3,200.8730
-872.3420
Pretax Income
-8,496.4390
-8,359.2450
-52,023.4220
-4,526.9050
Tax Provision
-859.6830
-1,046.9850
-234.5420
--
Net Income Common Stockholders
-7,636.7560
-7,312.2600
-51,788.8800
-4,526.9050
Diluted NI Available to Com Stockholders
-7,636.7560
-7,312.2600
-51,788.8800
-4,526.9050
Basic EPS
-0.20
-0.19
-1.50
-0.12
Diluted EPS
-0.20
-0.19
-1.50
-0.12
Basic Average Shares
38,089.5600
38,485.2630
34,466.2580
37,560.2490
Diluted Average Shares
38,089.5600
38,485.2630
34,466.2580
37,560.2490
Total Operating Income as Reported
-8,876.3910
-9,042.8510
-6,653.8050
-3,652.4330
Total Expenses
14,318.4670
14,667.9750
50,263.9150
3,652.4330
Net Income from Continuing & Discontinued Operation
-7,636.7560
-7,312.2600
-51,788.8800
-4,526.9050
Normalized Income
-8,123.4725
-7,676.4898
-48,602.4378
-3,654.5630
Interest Income
1,386.0520
1,386.0520
693.0270
--
Interest Expense
1,616.1690
1,165.4180
160.0350
2.1300
Net Interest Income
-132.1790
287.1650
536.3170
-2.1300
EBIT
-6,880.2700
-7,193.8270
-51,863.3870
-4,524.7750
EBITDA
-5,732.0190
-6,179.6660
-51,741.3650
-4,523.0760
Reconciled Cost of Revenue
4,611.4380
4,721.2780
1,023.2570
--
Reconciled Depreciation
1,148.2510
1,014.1610
122.0220
1.6990
Net Income from Continuing Operation Net Minority Interest
-7,636.7560
-7,312.2600
-51,788.8800
-4,526.9050
Total Unusual Items Excluding Goodwill
541.5070
416.3810
-3,200.8730
-872.3420
Total Unusual Items
541.5070
416.3810
-3,200.8730
-872.3420
Normalized EBITDA
-6,273.5260
-6,596.0470
-48,540.4920
-3,650.7340
Tax Rate for Calcs
0.0001
0.0001
0
--
Tax Effect of Unusual Items
54.7905
52.1512
-14.4308
--
6/30/2022 - 3/2/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.2930
0.00%
FLUI.ST Fluicell AB (publ)
12.98
+4.51%
2GH.BE Merus NV
35.80
-0.56%
SIMRIS-B.ST Simris Group AB (PUBL)
0.0836
-13.64%
22Z.SG Zealand Pharma A/S
61.14
+8.98%
5KW.F SkinBioTherapeutics plc
0.2000
0.00%
DBP-B.ST Double Bond Pharmaceutical Int.
0.2710
0.00%
HPHA.F Heidelberg Pharma AG
2.6200
+0.77%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
CHOSA.ST CHOSA Oncology AB
0.6500
0.00%